Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail Acknowledges Chairman Receives Notice of Hearing from the OSC.


TORONTO -- Biovail Corporation (NYSE NYSE

See: New York Stock Exchange
:BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency
)(TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
:BVF) today acknowledged a proceeding commenced by staff of the Ontario Securities Commission The Ontario Securities Commission (OSC) is a regulatory agency which administers and enforces securities legislation in the Canadian province of Ontario. The OSC is an Ontario Crown corporation which reports to the Ontario legislature through the Minister of Finance.  (OSC O.S.C. n. short for Order to Show Cause. (See: Order to Show Cause) ) against Chairman Eugene Melnyk and a former Director, among others. Additional information on this matter can be obtained on the OSC's Web site.

Biovail, its Board and its management team express their continued confidence in Mr. Melnyk's ability to lead the corporation as Chairman of Biovail's Board. Biovail will not be commenting further on this matter at this time.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the company's Web site at www.biovail.com.

For further information, please contact Ken Howling at 905-286-3000 or send inquiries to ir@biovail.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Jul 31, 2006
Words:136
Previous Article:Indevus Pharmaceuticals to Announce Third Quarter Fiscal 2006 Financial Results on August 3, 2006; Company to Conduct Conference Call and Webcast.
Next Article:BG North America Launches the BG US Challenge Presented By Fortune.
Topics:



Related Articles
Air-launched rocket orbits two satellites.
Reasonable compensation for closely held corporations.
FDA APPROVES BIOVAIL'S GENERIC PROCARDIA XL 30MG DOSAGE.
SGI SYSTEMS WILL MAKE THE OHIO SUPERCOMPUTER CENTER A WORLD LEADER IN PRODUCTION CLUSTER COMPUTING.
Hostage/barricade management: a hidden conflict within law enforcement.
BIOVAIL EXTENDS MARKETING PACT FOR ZOVIRAX OINTMENT/CREAM.
Court has jurisdiction to review equivalent hearings.
A blind eye to discrimination: Scott Bloch, the Bush appointee who tried to ditch protections for gay federal employees, has a new scandal on his...
Biovail Announces Results of 2005 Annual and Special Meeting of Shareholders; Chairman Eugene Melnyk Provides Governance Update; Chief Executive...
Biovail Chairman Eugene Melnyk Announces Retirement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles